CEO Corner

CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of.  

  • Successfully Transforming An Organization: An Active Approach
    Successfully Transforming An Organization: An Active Approach

    Rich Daly, Chairman & CEO of Neuralstem, Inc., pens this month column and gives some enlightening anecdotes about what it takes to make "transformational" changes at a biopharma company.

  • Collaborating To Stem The Tide Of Emerging Antimicrobial Resistance
    Collaborating To Stem The Tide Of Emerging Antimicrobial Resistance

    Jeffrey Stein, Ph.D., president and CEO of Cidara Therapeutics, discusses what needs to be done now by drug companies and healthcare providers alike to stem the tide of emerging antimicrobial resistance, including collaboration to address market barriers.

  • The Biotech CEO — It’s Not For Everyone
    The Biotech CEO — It’s Not For Everyone

    I’ve often described the challenge of developing new medicines as analogous to the difficulty of climbing the highest mountains on Earth. If one follows that analogy, then seeking to develop a new treatment for Alzheimer’s disease is like climbing K2, the second highest peak — in winter. That feat has not yet been accomplished, and those who aspire to do so describe it as their last frontier. Similarly, the brain is one of the last frontiers in medicine and drug development.

  • The Case For A Healthcare Futures Market
    The Case For A Healthcare Futures Market

    Now is the time to develop a novel financial instrument which will provide risk transfer, transparency, and more certainty. A futures market in healthcare is a product whose time has come.

  • Understanding The Many Faces Of Innovation
    Understanding The Many Faces Of Innovation

    By its very definition, innovation may travel long and painful paths, require repeated failure, and invite numerous mistakes to gather experience for bringing forward something new. Lady luck also intervenes occasionally, as well.

  • Why More Incentives Are Needed To Tackle Antibiotic Resistance
    Why More Incentives Are Needed To Tackle Antibiotic Resistance

    Antibiotic resistance is a real and immediate threat that is beginning to garner the global attention it needs and deserves. During a meeting of the United Nations in September 2016, the entire General Assembly — 193 nations — reaffirmed its commitment to developing national action plans on combatting antibiotic resistance.

  • An Insider’s View Of Life Outside The Academic Gilded Cage
    An Insider’s View Of Life Outside The Academic Gilded Cage

    There is a lyric from an old Bob Seger song in which the aging songwriter, lamenting the loss of his youthful prowess once filled with vim and vigor, wonders where the time went (“20 years now; where’d they go; 20 years; I don’t know”).

  • Can Financial Markets Solve The Ever-Increasing Costs of Healthcare?
    Can Financial Markets Solve The Ever-Increasing Costs of Healthcare?

    Why hasn't the healthcare industry evolved into vertical segmentation like other industries? Until now, it's because there has been no systematic way to hedge/transfer either institutional or operating risk in the healthcare system because information gathering and delivery is generally limited and poorly organized.

  • Biotechnology: The Hope For Rare Diseases
    Biotechnology: The Hope For Rare Diseases

    John Crowley, chairman and CEO of Amicus Therapeutics discusses why biotechs in the rare disease space face particularly unique and fundamental challenges.

  • Drug Company Discovery & Commercialization: An Election Year Analogy
    Drug Company Discovery & Commercialization: An Election Year Analogy

    As I consider the move from clinical to commercialization, it reminds me of the American electoral system – primary elections that are tightly focused and a general election where a candidate faces a vastly broader audience and has the opportunity to engage on a much larger stage and with far greater impact.

More From CEO Corner

LIFE SCIENCE EVENTS

Sara young September 20 - 22, 2017
Charlotte, NC
Improving Product Quality During Technical Transfer – Minimizing Risk, Maximizing Results September 20, 2017
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
The HireLifeScience.com Career Fair 2017 September 26, 2017
Edison, NJ
American Pharma Outsourcing September 27 - 28, 2017
Boston, MA
American Pharma Outsourcing Summit 2017 September 27 - 28, 2017
Boston, MA
Selecting a CMO/CDMO: 11 Best Practices For Sourcing The Right Partner September 28, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
8th Animal Health and Veterinary Medicine Congress October 2 - 4, 2017
Toronto, ON
Fisheries 2017 October 2 - 4, 2017
Toronto, ON
Organizational Strategies for Reducing Human Error in GMP Environments October 3, 2017
1:00 - 2:30 PM EDT, Online training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
American Medical Device Summit October 4 - 5, 2017
Chicago, IL